Cronos Group Inc. (CRON.TO)
CAD 2.57
(-0.77%)
CAD 2.57
(-0.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.9 Million USD | -0.5% |
| 2022 | 11.96 Million USD | 168.26% |
| 2021 | -17.53 Million USD | 32.13% |
| 2020 | -25.83 Million USD | -44.61% |
| 2019 | -17.86 Million CAD | -315.93% |
| 2018 | 8.27 Million CAD | 43.89% |
| 2017 | 5.74 Million CAD | 287.76% |
| 2016 | 1.48 Million CAD | 1716.92% |
| 2015 | 81.6 Thousand CAD | 353.72% |
| 2014 | -32.16 Thousand CAD | 83.56% |
| 2013 | -195.61 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 6.29 Million USD | 40.46% |
| 2024 Q1 | 4.48 Million USD | 134.34% |
| 2023 Q1 | 2.38 Million USD | 1117.09% |
| 2023 FY | 11.9 Million USD | -0.5% |
| 2023 Q4 | 1.91 Million USD | -51.81% |
| 2023 Q3 | 3.97 Million USD | 28.11% |
| 2023 Q2 | 3.09 Million USD | 30.21% |
| 2022 Q2 | 4.12 Million USD | -40.51% |
| 2022 FY | 11.96 Million USD | 168.26% |
| 2022 Q1 | 6.92 Million USD | 256.46% |
| 2022 Q4 | -234 Thousand USD | -120.22% |
| 2022 Q3 | 1.15 Million USD | -71.92% |
| 2021 Q4 | 1.94 Million USD | 366.16% |
| 2021 Q1 | -2.96 Million USD | 80.11% |
| 2021 FY | -17.53 Million USD | 32.13% |
| 2021 Q3 | -730 Thousand USD | 95.38% |
| 2021 Q2 | -15.78 Million USD | -432.7% |
| 2020 Q2 | -2.95 Million USD | 54.4% |
| 2020 Q1 | -6.47 Million USD | 68.22% |
| 2020 Q4 | -14.89 Million USD | -869.29% |
| 2020 Q3 | -1.53 Million USD | 47.95% |
| 2020 FY | -25.83 Million USD | -44.61% |
| 2019 Q3 | -14.62 Million CAD | -423.18% |
| 2019 FY | -17.86 Million CAD | -315.93% |
| 2019 Q4 | -20.37 Million CAD | -39.29% |
| 2019 Q2 | 4.52 Million CAD | -54.62% |
| 2019 Q1 | 9.97 Million CAD | 3917.8% |
| 2018 Q1 | 1.49 Million CAD | -37.67% |
| 2018 Q4 | 248.24 Thousand CAD | -84.68% |
| 2018 FY | 8.27 Million CAD | 43.89% |
| 2018 Q3 | 1.62 Million CAD | -66.41% |
| 2018 Q2 | 4.82 Million CAD | 223.2% |
| 2017 Q3 | 1.61 Million CAD | 87.42% |
| 2017 FY | 5.74 Million CAD | 287.76% |
| 2017 Q4 | 2.39 Million CAD | 48.26% |
| 2017 Q2 | 862.06 Thousand CAD | 11.04% |
| 2017 Q1 | 776.38 Thousand CAD | -41.68% |
| 2016 Q1 | -37.91 Thousand CAD | 13.98% |
| 2016 FY | 1.48 Million CAD | 1716.92% |
| 2016 Q4 | 1.33 Million CAD | 580.65% |
| 2016 Q3 | 195.58 Thousand CAD | 1172.95% |
| 2016 Q2 | -18.22 Thousand CAD | 51.93% |
| 2015 Q2 | -37.83 Thousand CAD | 1.54% |
| 2015 FY | 81.6 Thousand CAD | 353.72% |
| 2015 Q4 | -44.08 Thousand CAD | -48.78% |
| 2015 Q3 | -29.62 Thousand CAD | 21.69% |
| 2015 Q1 | -38.42 Thousand CAD | 0.0% |
| 2014 FY | -32.16 Thousand CAD | 83.56% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | -195.61 Thousand CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aurora Cannabis Inc. | 131.46 Million CAD | 90.941% |
| Avicanna Inc. | 6.65 Million CAD | -78.849% |
| Avant Brands Inc. | 12.43 Million CAD | 4.207% |
| Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 4895.152% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | -14.907% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 92.199% |
| MediPharm Labs Corp. | 5.85 Million CAD | -103.399% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | 66.045% |
| Canopy Growth Corporation | 80.88 Million CAD | 85.276% |
| Willow Biosciences Inc. | -659 Thousand CAD | 1907.132% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | 44.029% |